KEY FEATURES
| Full Name | Apolipoprotein C3 |
|---|---|
| Synonym | APOC3;ApoC-III;MGC150353;Apo-CIII;APOCIII;apoC-III;Apolipoprotein C3;apo-CIII;apolipoprotein C-III; |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.19ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse ApoC3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse ApoC3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse ApoC3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse ApoC3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse ApoC3. You can calculate the concentration of Mouse ApoC3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse ApoC3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.05 | 1.92 | 7.7 | 0.99 | 1.88 | 7.92 |
| Standard deviation | 0.07 | 0.08 | 0.25 | 0.06 | 0.08 | 0.27 |
| CV(%) | 6.57 | 4 | 3.27 | 6.01 | 4.11 | 3.41 |
RECOVERY
The recovery of Mouse ApoC3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-104 | 97 |
| EDTA plasma (n=8) | 89-103 | 94 |
| Cell culture media (n=8) | 89-102 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse ApoC3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with APOC3 ELISA Kits
| APOE ELISA Kit | publications with APOC3 and APOE |
| APOA5 ELISA Kit | publications with APOC3 and APOA5 |
| APOA1 ELISA Kit | publications with APOC3 and APOA1 |
| LPL ELISA Kit | publications with APOC3 and LPL |
| APOB ELISA Kit | publications with APOC3 and APOB |
| APOA4 ELISA Kit | publications with APOC3 and APOA4 |
| APOC2 ELISA Kit | publications with APOC3 and APOC2 |
| APOA2 ELISA Kit | publications with APOC3 and APOA2 |
| PPARG ELISA Kit | publications with APOC3 and PPARG |
| PPARA ELISA Kit | publications with APOC3 and PPARA |
Pathways associated with APOC3 ELISA Kit
| Chylomicron-mediated Lipid Transport Pathway | Chylomicron-mediated Lipid Transport Pathway |
| Disease Pathway | Disease Pathway |
| Diseases Associated With Visual Transduction Pathway | Diseases Associated With Visual Transduction Pathway |
| HDL-mediated Lipid Transport Pathway | HDL-mediated Lipid Transport Pathway |
| Lipid Digestion, Mobilization, And Transport Pathway | Lipid Digestion, Mobilization, And Transport Pathway |
| Lipoprotein Metabolism Pathway | Lipoprotein Metabolism Pathway |
| Metabolism Pathway | Metabolism Pathway |
| Metabolism Of Lipids And Lipoproteins Pathway | Metabolism Of Lipids And Lipoproteins Pathway |
| PPAR Signaling Pathway | PPAR Signaling Pathway |
Diseases associated with APOC3 ELISA Kit
| Cardiovascular Diseases | publications with APOC3 and Cardiovascular Diseases |
| Coronary Disease | publications with APOC3 and Coronary Disease |
| Dyslipidemias | publications with APOC3 and Dyslipidemias |
| Hypertriglyceridemia | publications with APOC3 and Hypertriglyceridemia |
| Heart Diseases | publications with APOC3 and Heart Diseases |
| Atherosclerosis | publications with APOC3 and Atherosclerosis |
| Hyperlipidemias | publications with APOC3 and Hyperlipidemias |
| Insulin Resistance | publications with APOC3 and Insulin Resistance |
| Obesity | publications with APOC3 and Obesity |
| Fatty Liver | publications with APOC3 and Fatty Liver |
Organs/Tissues associated with APOC3 ELISA Kit
| Liver | publications with APOC3 and Liver |
| Heart | publications with APOC3 and Heart |
| Connective Tissue | publications with APOC3 and Connective Tissue |
| Muscle | publications with APOC3 and Muscle |
| Kidney | publications with APOC3 and Kidney |
| Brain | publications with APOC3 and Brain |
| Lung | publications with APOC3 and Lung |